Baidu
map

左右冠同时造影在CTO病变中的应用(图)

2015-12-02 网络 MedSci原创

左右冠同时造影在CTO病变中的应用

左右冠同时造影在CTO病变中的应用

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1862756, encodeId=1ae61862e5609, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Nov 10 17:15:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993678, encodeId=203a19936e843, content=<a href='/topic/show?id=675254302e' target=_blank style='color:#2F92EE;'>#CTO病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5430, encryptionId=675254302e, topicName=CTO病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Fri May 06 21:15:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493990, encodeId=26e11493990f2, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Fri Dec 04 00:15:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2016-11-10 gao_jian4217
  2. [GetPortalCommentsPageByObjectIdResponse(id=1862756, encodeId=1ae61862e5609, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Nov 10 17:15:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993678, encodeId=203a19936e843, content=<a href='/topic/show?id=675254302e' target=_blank style='color:#2F92EE;'>#CTO病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5430, encryptionId=675254302e, topicName=CTO病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Fri May 06 21:15:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493990, encodeId=26e11493990f2, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Fri Dec 04 00:15:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1862756, encodeId=1ae61862e5609, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5422, encryptionId=0b69542242, topicName=CTO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c66088, createdName=gao_jian4217, createdTime=Thu Nov 10 17:15:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993678, encodeId=203a19936e843, content=<a href='/topic/show?id=675254302e' target=_blank style='color:#2F92EE;'>#CTO病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5430, encryptionId=675254302e, topicName=CTO病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Fri May 06 21:15:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493990, encodeId=26e11493990f2, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Fri Dec 04 00:15:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-04 sodoo

相关资讯

Circulation:造影确诊心梗心脏破裂一例

患者再发PEA和心脏停搏,心电图提示心脏破裂。尝试心包穿刺术失败后,患者处于心源性休克状态,应用血管升压药物,进入导管室。

Circulation:心肌声学造影技术发现可卡因收缩冠脉微血管新证据

基础水平以及低剂量可卡因心肌声学影像学表现 图注:上图为,不同时间间隔左心室心肌声学显像二维图像。表A,基础水平以及摄入多巴酚丁胺条件下心肌收缩时间-强度曲线表B,基础水平以及摄入多巴酚丁胺条件下心肌灌注对比表C,基础水平以及摄入多巴酚丁胺条件下心肌灌注/MVO2 可卡因是目前世界上第二大滥用药物,长期使用可卡因可增加心血管事件风险,它也是年轻人发生急性冠脉综合征的主要因素之一。尽管可卡因

EBM:以崭新之生物医学造影技术研究癌症发展模式

由Gillies博士所领导的亚历桑纳癌症中心及摩非特癌症中心(Moffitt Cancer Center)的研究团队目前已经证实了,藉由崭新的核磁共振造影技术,以非侵入性的方式监控乳癌模式动物中癌细胞的生长。此一量化造影技术测量与癌细胞生长息息相关的癌组织内水份扩散。此一结果已发表于2012年11月号《实验生物医学》期刊,将有助于发展崭新的癌症研究模式。 Gillies博士指出,先前在缺乏影像技

Baidu
map
Baidu
map
Baidu
map